Screener
Protagonist Therapeutics PTGX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's price / sales?
- Protagonist Therapeutics (PTGX) reported price / sales of 28× in Q2 2026.
- How has Protagonist Therapeutics's price / sales changed year-over-year?
- Protagonist Therapeutics's price / sales increased by 75.8% year-over-year, from 15.9× to 28×.
- What is the long-term trend for Protagonist Therapeutics's price / sales?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's price / sales has grown at a 18.8% compound annual growth rate (CAGR), from 59.7× to 118.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Protagonist Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude